License
CRID License
The CRID (Clinical Research IDentifier) is a unique patient identification service designed to support rare disease research. It is provided free of charge to individuals participating in rare disease research studies.
Non-profit rare disease organizations can use the CRID platform to validate CRID identifiers quickly and securely.
For access to essential IRB (Institutional Review Board) documentation or additional information, please contact us at crid@clirinx.com.
CRID API License ($$)
Please contact us at crid@clirinx.com to dicscuss your API requirements.
News
Jan 9th, 2025
CLIRINX is committed to keeping CRID operational because it plays a critical role in advancing rare disease research. The platform remains highly active and continues to provide invaluable service to the rare disease community.
Nov 14th, 2024
The CRID server infrastructure has been upgraded to use the latest Amazon AWS components! This enhancement improves performance, security and reliability.
Mar 7th, 2024
NR2F1 Foundation | Webinar | CRID with Gerry Nesbitt
Mar 1st, 2024
Creating a New Account is now a 2-step process to help ensure all email addresses are genuine.
Jan 16th, 2024
Cure GABA-A | Launch and Learn | CRID with Gerry Nesbitt
Sept 21st, 2022
CRID RESTful API Launched
Aug 23rd, 2022
CRID Training Video
Dec 2nd-6th, 2022
American Epilepsy Society Meeting (Nashville, TN)